Tae Hyun Hwang

Quantum computing team including Sunho Park wins competitive award

Their work focused on determining tissue and electrophysiological properties of the heart based on existing imaging approaches using quantum computing.

Vanderbilt-developed AI platform validated for molecular mapping of tissues

The advancement transforms how scientists and clinicians can visualize and analyze complex tissues on a high-resolution map of cellular landscapes across entire tissue sections.

VUMC’s Section of Surgical Sciences and LG forge collaboration on AI initiatives for medical needs

The collaboration will center on the Molecular AI Initiative’s pioneering platform, which uses AI-driven 3D spatial multimodal research to build predictive, high-fidelity models of a patient’s disease at the molecular level.

AI researchers develop new technologies for cancer care  

These new technologies showcase how VUMC researchers are using the power of AI to meet a wide range of medical needs.

Vanderbilt University Medical Center researchers to lead AI-powered cancer workshop at AACR 2025 

VUMC’s session will provide a deep dive into how AI-driven 3D spatial molecular and multimodal approaches are transforming the landscape of oncology research.

An AI-driven rendering and analysis of a holotomography-based 3D reconstruction of a tumor tissue sample derived from a spatial molecular experimental platform. Cancer cells (blue), stromal cells (green), and immune cells (red) are highlighted, while the extracellular matrix (ECM) appears in translucent green with a green arrow indicating its orientation. By integrating spatial molecular measurements, this approach offers single-cell and subcellular functional characterization, providing key insights into cellular interactions and communication in a three-dimensional context to deepen our understanding of the tissue’s architecture and composition.

VUMC to launch Molecular AI initiative to spur precision medicine, transplantation

The leader of the new initiative, Tae Hyun Hwang, PhD, will work to apply AI and other revolutionary technologies, including advanced molecular imaging techniques, to clinical practice.